CTOs on the Move

TELA Bio

www.telabio.com

 
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient`s own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient`s natural healing response while minimizing long-term exposure to permanent synthetic materials.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.telabio.com
  • 1 Great Valley Parkway Suite 24
    Malvern, PA USA 19355
  • Phone: 484.320.2930

Executives

Name Title Contact Details
Ryan Ash
Director of IT Profile

Funding

TELA Bio raised $25M on 10/30/2017

Similar Companies

Clinical Technology Inc

Clinical Technology Inc is a Broadview Heights, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LifeGas

LifeGas is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Armetheon

Armetheon, Inc. is a privately held San Francisco Bay area-based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases. The company was founded in 2011 by experienced biotech entrepreneurs and drug developers. Armetheon’s two late-stage small molecule drug candidates are for use in the areas of oral anti-coagulation and anti-arrhythmia for atrial fibrillation. The company was founded with the idea that drug innovations can happen by building on the success of proven medications. We create solutions that are within the same class of medication and that utilize the same mechanism of action as existing therapies. This development approach has the ability to offer peace of mind to patients while benefitting physicians, who may wish to reduce safety concerns, side effects and adverse events for their patients.  

HOWARD INSTRUMENTS

HOWARD INSTRUMENTS is a Tuscaloosa, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. Our primary focus is helping physicians conquer even the most difficult disease states, including arterial calcium, given the complications it presents for the millions who suffer from peripheral arterial disease (PAD) and coronary artery disease (CAD). CSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe, effective, economical medical devices that improve patient outcomes.